Performances of artificial intelligence in detecting pathologic myopia: a systematic review and meta-analysis

Yue Zhang1,2, Yilin Li3, Jing Liu1,2

  • 1Department of Ophthalmology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, China.

Eye (London, England)
|April 28, 2023
PubMed
Abstract

Insights

Artificial intelligence (AI) shows excellent performance in detecting pathologic myopia (PM) and its complications using fundus and OCT images. This systematic review confirms AI

Area of Science:

  • Ophthalmology and Medical Imaging
  • Artificial Intelligence in Healthcare
  • Diagnostic Accuracy Studies

Background:

  • Pathologic myopia (PM) is a leading cause of vision impairment and blindness.
  • Existing AI applications focus on PM diagnosis and classification.
  • This study evaluates AI performance in detecting PM and related complications.

Approach:

  • Systematic review and meta-analysis of studies published before December 20, 2022.
  • Searched major scientific databases (PubMed, Scopus, Embase, Web of Science, IEEE Xplore).
  • Assessed study quality using QUADAS-2 and pooled diagnostic accuracy metrics (SEN, SPE, AUC) for AI models using fundus or OCT images.

Key Points:

  • Included 22 studies, with 14 in quantitative analysis.
  • AI demonstrated high sensitivity (0.95) and specificity (0.97) for PM detection, with an AUC of 0.99.
  • AI achieved an AUC of 0.99 for detecting PM-related choroidal neovascularization (CNV).

Conclusions:

  • AI algorithms exhibit excellent performance in detecting pathologic myopia.
  • AI accurately identifies PM-related complications like CNV from fundus and OCT images.
  • AI holds significant promise for improving the diagnosis and management of PM.

Related Concept Videos